We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00003079
Recruitment Status : Completed
First Posted : May 27, 2004
Last Update Posted : February 17, 2010
National Cancer Institute (NCI)
Information provided by:
Virginia Commonwealth University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : May 2001
  Study Completion Date : May 2001